Cargando…

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()

BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galand, Vincent, Hwang, Elliot, Gandjbakhch, Estelle, Sebag, Frédéric, Marijon, Eloi, Boveda, Serge, Leclercq, Christophe, Defaye, Pascal, Rosier, Arnaud, Martins, Raphaël Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141722/ https://www.ncbi.nlm.nih.gov/pubmed/34088625 http://dx.doi.org/10.1016/j.acvd.2021.02.005

Ejemplares similares

Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study
por: Garcia, Rodrigue, et al.
Publicado: (2023)

Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry
por: Providência, Rui, et al.
Publicado: (2016)

Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023)

Regional disparity on patient characteristics and perceptions after implantable cardioverter-defibrillator implantation: results from an EHRA patient survey
por: Januszkiewicz, Łukasz, et al.
Publicado: (2023)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study
por: Garcia, Rodrigue, et al.
Publicado: (2020)

Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection
por: Sacher, Frederic, et al.
Publicado: (2020)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Performance of an automated external cardioverter defibrillator for inhospital ventricular malignant arrhythmia
por: Timerman, S, et al.
Publicado: (2003)

Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry
por: Perrin, Tilman, et al.
Publicado: (2019)

Validation of an apnea and hypopnea detection algorithm implemented in implantable cardioverter defibrillators. The AIRLESS study
por: Defaye, Pascal, et al.
Publicado: (2019)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
por: Cheema, Aamir, et al.
Publicado: (2010)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Genome-Wide Association of Implantable Cardioverter-Defibrillator Activation With Life-Threatening Arrhythmias
por: Murray, Sarah S., et al.
Publicado: (2012)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

How is Contact Force implemented in routine clinical practice? Results from a French National and Monaco Survey
por: Bun, Sok‐Sithikun, et al.
Publicado: (2019)

Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
por: Hauck, Christian, et al.
Publicado: (2022)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
por: Back, Steven H, et al.
Publicado: (2019)

Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
por: Burch, Ashley E., et al.
Publicado: (2019)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
por: Okada, Kozo, et al.
Publicado: (2020)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
por: Malanchini, G., et al.
Publicado: (2021)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial
por: Hindricks, Gerhard, et al.
Publicado: (2014)

Clinical Course of Dual-Chamber Implantable Cardioverter-Defibrillator Recipients followed by Cardiac Remote Monitoring: Insights from the LION Registry
por: Schwab, Joerg O., et al.
Publicado: (2018)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants
por: Touboul, Olivier, et al.
Publicado: (2022)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
por: Zhou, You, et al.
Publicado: (2019)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

The extravascular implantable cardioverter‐defibrillator: The pivotal study plan
por: Crozier, Ian, et al.
Publicado: (2021)

Radiofrequency remote monitor software patch update without cybersecurity implantable cardioverter-defibrillator firmware update increases the risk of inappropriate implantable cardioverter-defibrillator therapies
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4fl23j559qkqmf4di9281jmp92